Literature DB >> 18795992

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.

A A Khorana, C W Francis, K E Menzies, J-G Wang, O Hyrien, J Hathcock, N Mackman, M B Taubman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18795992      PMCID： PMC2848502          DOI： 10.1111/j.1538-7836.2008.03156.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  10 in total

1.  Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.

Authors:  Nobuhiro Nitori; Yoshinori Ino; Yukihiro Nakanishi; Tesshi Yamada; Kazufumi Honda; Kazuyoshi Yanagihara; Tomoo Kosuge; Yae Kanai; Masaki Kitajima; Setsuo Hirohashi
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

2.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

Review 3.  Pancreatic cancer and thromboembolic disease.

Authors:  Alok A Khorana; Robert L Fine
Journal:  Lancet Oncol       Date:  2004-11       Impact factor: 41.316

4.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

Authors:  Z Mallat; H Benamer; B Hugel; J Benessiano; P G Steg; J M Freyssinet; A Tedgui
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

5.  Cancer statistics, 2007.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

6.  Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

Authors:  M E T Tesselaar; F P H T M Romijn; I K Van Der Linden; F A Prins; R M Bertina; S Osanto
Journal:  J Thromb Haemost       Date:  2006-12-13       Impact factor: 5.824

7.  Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.

Authors:  M Mandalà; M Reni; S Cascinu; S Barni; I Floriani; S Cereda; R Berardi; S Mosconi; V Torri; R Labianca
Journal:  Ann Oncol       Date:  2007-07-28       Impact factor: 32.976

8.  The presence and release of tissue factor from human platelets.

Authors:  Farooq A Siddiqui; Hina Desai; Ali Amirkhosravi; Mildred Amaya; John L Francis
Journal:  Platelets       Date:  2002-06       Impact factor: 3.862

9.  Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.

Authors:  Alok A Khorana; Steven A Ahrendt; Charlotte K Ryan; Charles W Francis; Ralph H Hruban; Ying Chuan Hu; Galen Hostetter; Jennifer Harvey; Mark B Taubman
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

10.  Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer.

Authors:  K Uno; S Homma; T Satoh; K Nakanishi; D Abe; K Matsumoto; A Oki; H Tsunoda; I Yamaguchi; T Nagasawa; H Yoshikawa; K Aonuma
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640
  10 in total
  101 in total

Review 1.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

Review 2.  Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.

Authors:  Raj S Kasthuri; Sam L Glover; Jeremiah Boles; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

Review 3.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

4.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

Review 5.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

6.  Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.

Authors:  B N Yamaja Setty; Nigel S Key; A Koneti Rao; Suhita Gayen-Betal; Suba Krishnan; Carlton D Dampier; Marie J Stuart
Journal:  Br J Haematol       Date:  2012-02-24       Impact factor: 6.998

7.  Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.

Authors:  R D Lee; D A Barcel; J C Williams; J G Wang; J C Boles; D A Manly; N S Key; N Mackman
Journal:  Thromb Res       Date:  2011-07-06       Impact factor: 3.944

8.  Physiological levels of blood coagulation factors IX and X control coagulation kinetics in an in vitro model of circulating tissue factor.

Authors:  Garth W Tormoen; Ayesha Khader; András Gruber; Owen J T McCarty
Journal:  Phys Biol       Date:  2013-04-15       Impact factor: 2.583

9.  Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Authors:  Jeffrey I Zwicker; Howard A Liebman; Kenneth A Bauer; Thomas Caughey; Federico Campigotto; Rachel Rosovsky; Simon Mantha; Craig M Kessler; Jonathan Eneman; Vidya Raghavan; Heinz-Joseph Lenz; Andrea Bullock; Elizabeth Buchbinder; Donna Neuberg; Bruce Furie
Journal:  Br J Haematol       Date:  2012-12-13       Impact factor: 6.998

Review 10.  Biomolecular markers of cancer-associated thromboembolism.

Authors:  Diana L Hanna; Richard H White; Ted Wun
Journal:  Crit Rev Oncol Hematol       Date:  2013-03-21       Impact factor: 6.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.